We confirmed our results using a third dataset, including 22 primary PCa and 29 CRPC BM samples (GSE32269), where we observed that SPP1 is significantly upregulated in the metastatic disease (Supplementary Fig. 6A). This evidence concerns the gene SPP1 and posterior cortical atrophy.